- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
股价的强势特征已经确立，短线可能回调。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有230家主力机构披露2025-06-30报告期持股数据，持仓量总计3.91亿股，占流通A股62.26%
- 波段诊断：
-
技术面诊股
诊断结果：9.0技术面打败了98%的股票
技术面评分前10的股票
近期的平均成本为23.92元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为23.92元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"23.92","date":1765269807,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，明显跑赢行业平均水平。
[{"date":"2025.12.10","stock":"2.17","trade":"-0.11","ind":"-0.23"},{"date":"2025.12.09","stock":"1.56","trade":"-1.56","ind":"-0.37"},{"date":"2025.12.08","stock":"0.43","trade":"-0.39","ind":"0.54"},{"date":"2025.12.05","stock":"-0.78","trade":"-0.36","ind":"0.70"},{"date":"2025.12.04","stock":"0.17","trade":"-1.07","ind":"-0.06"},{"date":"2025.12.03","stock":"0.65","trade":"1.34","ind":"-0.51"},{"date":"2025.12.02","stock":"1.46","trade":"-0.75","ind":"-0.42"},{"date":"2025.12.01","stock":"4.37","trade":"1.06","ind":"0.65"},{"date":"2025.11.28","stock":"-0.73","trade":"-0.86","ind":"0.34"},{"date":"2025.11.27","stock":"0.32","trade":"0.50","ind":"0.29"},{"date":"2025.11.26","stock":"1.63","trade":"0.52","ind":"-0.15"},{"date":"2025.11.25","stock":"-0.69","trade":"1.77","ind":"0.87"},{"date":"2025.11.24","stock":"-0.14","trade":"0.97","ind":"0.05"},{"date":"2025.11.21","stock":"-0.73","trade":"-3.30","ind":"-2.45"},{"date":"2025.11.20","stock":"-0.64","trade":"0.07","ind":"-0.40"},{"date":"2025.11.19","stock":"-0.27","trade":"-1.77","ind":"0.18"},{"date":"2025.11.18","stock":"0.36","trade":"-1.55","ind":"-0.81"},{"date":"2025.11.17","stock":"-0.45","trade":"-1.44","ind":"-0.46"},{"date":"2025.11.14","stock":"0.50","trade":"1.17","ind":"-0.97"},{"date":"2025.11.13","stock":"0.05","trade":"0.48","ind":"0.73"},{"date":"2025.11.12","stock":"1.44","trade":"0.85","ind":"-0.07"}]
江中药业,上证指数,中药指数
压力支撑
该股压力位为23.64元，支撑位为23.20元。
[{"text":"\u538b\u529b\u4f4d","value":"23.64","date":1765296000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"23.20","date":1765296000,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.3资金面打败了62%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：12月10日 20:30
| 机构今日流向(万元) | -938.10 | 机构5日流向(万元) | -9385.47 |
| 机构10日流向(万元) | -14177.63 | 机构20日流向(万元) | -28384.99 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少415.37万股，其中基金净减仓25家，主力净增仓28家，暂未发现中长期投资价值。
截止2025-06-30，共230家主力机构（基金224家，保险公司1家，一般法人3家，社保基金1家，券商1家），持仓量总计39052.47万股，占流通A股62.26%
其中，基金持仓与2024-12-31相比：
增仓：30家 ，增持 226.84万股
减仓：55家 ，减持 866.34万股
新出现在主力名单中：133家 ，持有2243.89万股
从主力名单中消失：105家 ，原持有1451.8万股
其中，基金持仓与2024-12-31相比：
增仓：30家 ，增持 226.84万股
减仓：55家 ，减持 866.34万股
新出现在主力名单中：133家 ，持有2243.89万股
从主力名单中消失：105家 ，原持有1451.8万股
消息面诊股
诊断结果：5.9消息面打败了61%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 江中药业：12月9日获融资买入1486.14万元
2025-12-10 - 江中药业荣获2025“上证鹰·金质量”两项荣誉
2025-12-09 - 江中药业：12月8日获融资买入838.21万元
2025-12-09 - 华润江中旗下济生公司和江中饮片两家企业获评2025
2025-12-08 - 江中药业，“闷死人”的股价背后，或许还真值得去耐心
2025-12-07 - 江中药业：12月5日获融资买入1007.19万元
2025-12-06 - 行业周报|中药指数涨0.19%, 跑输上证指数0.
2025-12-05 - 江中药业：12月4日获融资买入961.92万元
2025-12-05 - 江中药业：12月3日获融资买入1045.20万元
2025-12-04 - 江中药业：12月2日获融资买入2450.85万元
2025-12-03
消息列表
| 一般消息 | 重大事项 | 关联交易 | 2025-10-29 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-22 |
| 利好 | 分红转增 | 10派5元(含税) | 2025-08-22 |
| 一般消息 | 重大事项 | 关联交易 | 2025-05-17 |
| 利好 | 分红转增 | 10派7元(含税) | 2025-03-20 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-03-20 |
| 一般消息 | 重大事项 | 关联交易 | 2025-03-20 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：5.3行业面打败了69%的股票
中药行业最新资金流向
近10日来该行业走势不明显，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，明显跑输大盘。
[{"date":"2025.12.10","price":"-0.23","value":"-0.11"},{"date":"2025.12.09","price":"-0.37","value":"-1.56"},{"date":"2025.12.08","price":"0.54","value":"-0.39"},{"date":"2025.12.05","price":"0.70","value":"-0.36"},{"date":"2025.12.04","price":"-0.06","value":"-1.07"},{"date":"2025.12.03","price":"-0.51","value":"1.34"},{"date":"2025.12.02","price":"-0.42","value":"-0.75"},{"date":"2025.12.01","price":"0.65","value":"1.06"},{"date":"2025.11.28","price":"0.34","value":"-0.86"},{"date":"2025.11.27","price":"0.29","value":"0.50"},{"date":"2025.11.26","price":"-0.15","value":"0.52"},{"date":"2025.11.25","price":"0.87","value":"1.77"},{"date":"2025.11.24","price":"0.05","value":"0.97"},{"date":"2025.11.21","price":"-2.45","value":"-3.30"},{"date":"2025.11.20","price":"-0.40","value":"0.07"},{"date":"2025.11.19","price":"0.18","value":"-1.77"},{"date":"2025.11.18","price":"-0.81","value":"-1.55"},{"date":"2025.11.17","price":"-0.46","value":"-1.44"},{"date":"2025.11.14","price":"-0.97","value":"1.17"},{"date":"2025.11.13","price":"0.73","value":"0.48"},{"date":"2025.11.12","price":"-0.07","value":"0.85"}]
上证指数,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 粤万年青 | 25.09% | -16.32% | 5.1分 |
| 2 | 太龙药业 | 11.53% | -0.53% | 5.7分 |
| 3 | 江中药业 | 9.50% | 3.59% | 6.9分 |
| 4 | 信邦制药 | 4.80% | 6.41% | 6.0分 |
| 5 | 嘉应制药 | 2.45% | -3.53% | 4.3分 |
| 6 | 汉森制药 | 0.00% | -2.70% | 5.5分 |
| 8 | 葵花药业 | -0.33% | -0.60% | 4.2分 |
| 10 | 沃华医药 | -1.09% | -2.46% | 5.4分 |
| 12 | 桂林三金 | -2.35% | -2.74% | 6.1分 |
| 14 | 康惠股份 | -2.39% | 1.49% | 5.4分 |
| 16 | 上海凯宝 | -2.63% | -2.78% | 5.1分 |
| 18 | 东阿阿胶 | -2.72% | -0.17% | 5.2分 |
| 20 | 马应龙 | -3.05% | 0.00% | 6.7分 |
| 22 | 启迪药业 | -3.59% | -2.42% | 4.8分 |
| 24 | 新光药业 | -4.05% | -8.14% | 5.0分 |
| 26 | 精华制药 | -4.22% | -5.98% | 5.1分 |
| 28 | 寿仙谷 | -4.57% | -1.24% | 4.8分 |
| 30 | 盘龙药业 | -5.11% | -8.12% | 4.8分 |
| 32 | 同仁堂 | -5.18% | -1.82% | 4.8分 |
| 34 | 羚锐制药 | -5.19% | -1.71% | 5.3分 |
| 36 | 益盛药业 | -5.42% | -11.27% | 4.9分 |
| 38 | 白云山 | -5.48% | -1.04% | 5.1分 |
| 40 | 奇正藏药 | -6.03% | -2.08% | 5.2分 |
| 42 | 佛慈制药 | -6.66% | -4.71% | 4.8分 |
| 44 | 方盛制药 | -6.96% | 0.97% | 5.4分 |
| 46 | 达仁堂 | -7.22% | -1.17% | 5.7分 |
| 48 | 步长制药 | -7.55% | -2.59% | 5.2分 |
| 50 | 广誉远 | -7.80% | -3.79% | 4.8分 |
| 52 | 吉林敖东 | -8.65% | 0.16% | 5.2分 |
| 54 | 益佰制药 | -9.17% | -6.45% | 4.9分 |
| 56 | 众生药业 | -9.41% | -10.10% | 4.3分 |
| 58 | 贵州百灵 | -10.02% | -1.62% | 4.7分 |
| 60 | 健民集团 | -10.43% | -4.08% | 4.6分 |
| 62 | 九芝堂 | -12.73% | -0.11% | 4.7分 |
| 64 | 珍宝岛 | -13.16% | -1.07% | 4.9分 |
| 66 | 恩威医药 | -14.13% | -6.86% | 4.4分 |
| 68 | 万邦德 | -16.45% | -3.91% | 4.4分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 4/109 ， 20/109。
[{"date":"2025-09-30","value":"17.85","vol":"4.74"},{"date":"2025-06-30","value":"13.38","vol":"3.98"},{"date":"2025-03-31","value":"7.11","vol":"2.21"},{"date":"2024-12-31","value":"20.49","vol":"4.80"},{"date":"2024-09-30","value":"16.81","vol":"2.91"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
17.85 | 13.38 | 7.11 | 20.49 | 16.81 |
| 行业(%) | 4.74 | 3.98 | 2.21 | 4.80 | 2.91 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"66.05","vol":"52.31"},{"date":"2025-06-30","value":"66.60","vol":"52.86"},{"date":"2025-03-31","value":"68.21","vol":"53.38"},{"date":"2024-12-31","value":"63.52","vol":"52.74"},{"date":"2024-09-30","value":"67.67","vol":"53.11"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
66.05 | 66.60 | 68.21 | 63.52 | 67.67 |
| 行业(%) | 52.31 | 52.86 | 53.38 | 52.74 | 53.11 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 34/109 ， 31/109。
[{"date":"2025-09-30","value":"-6.28","vol":"-7.31"},{"date":"2025-06-30","value":"-5.79","vol":"-7.31"},{"date":"2025-03-31","value":"-7.03","vol":"-7.18"},{"date":"2024-12-31","value":"-2.59","vol":"-7.35"},{"date":"2024-09-30","value":"-8.19","vol":"-5.11"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-6.28 | -5.79 | -7.03 | -2.59 | -8.19 |
| 行业(%) | -7.31 | -7.31 | -7.18 | -7.35 | -5.11 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"5.54","vol":"-2.54"},{"date":"2025-06-30","value":"5.80","vol":"2.98"},{"date":"2025-03-31","value":"5.91","vol":"-37.19"},{"date":"2024-12-31","value":"9.67","vol":"-146.29"},{"date":"2024-09-30","value":"7.09","vol":"61.78"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
5.54 | 5.80 | 5.91 | 9.67 | 7.09 |
| 行业(%) | -2.54 | 2.98 | -37.19 | -146.29 | 61.78 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 17/109 ， 19/109。
[{"date":"2025-09-30","value":"0.44","vol":"0.35"},{"date":"2025-06-30","value":"0.33","vol":"0.24"},{"date":"2025-03-31","value":"0.18","vol":"0.12"},{"date":"2024-12-31","value":"0.70","vol":"0.50"},{"date":"2024-09-30","value":"0.48","vol":"0.37"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.44 | 0.33 | 0.18 | 0.70 | 0.48 |
| 行业(次) | 0.35 | 0.24 | 0.12 | 0.50 | 0.37 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.01","vol":"1.73"},{"date":"2025-06-30","value":"1.47","vol":"1.18"},{"date":"2025-03-31","value":"0.85","vol":"0.61"},{"date":"2024-12-31","value":"3.73","vol":"2.42"},{"date":"2024-09-30","value":"2.26","vol":"1.81"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.01 | 1.47 | 0.85 | 3.73 | 2.26 |
| 行业(次) | 1.73 | 1.18 | 0.61 | 2.42 | 1.81 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"40.65","vol":"9.48"},{"date":"2025-06-30","value":"49.64","vol":"20.05"},{"date":"2025-03-31","value":"14.93","vol":"-0.23"},{"date":"2024-12-31","value":"23.46","vol":"15.64"},{"date":"2024-09-30","value":"-4.12","vol":"5.86"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 40.65 | 49.64 | 14.93 | 23.46 | -4.12 |
| 行业 | 9.48 | 20.05 | -0.23 | 15.64 | 5.86 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.46","vol":"1.02"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"2.11","vol":"1.45"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.46 | - | 2.11 | - |
| 行业 | 0.00 | 1.02 | 0.00 | 1.45 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 20/109 ， 16/109。
[{"date":"2025-09-30","value":"1.58","vol":"3.05"},{"date":"2025-06-30","value":"1.69","vol":"2.90"},{"date":"2025-03-31","value":"1.97","vol":"2.99"},{"date":"2024-12-31","value":"1.40","vol":"2.88"},{"date":"2024-09-30","value":"1.13","vol":"3.25"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.58 | 1.69 | 1.97 | 1.40 | 1.13 |
| 行业 | 3.05 | 2.90 | 2.99 | 2.88 | 3.25 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.30","vol":"2.21"},{"date":"2025-06-30","value":"1.37","vol":"2.13"},{"date":"2025-03-31","value":"1.67","vol":"2.22"},{"date":"2024-12-31","value":"1.11","vol":"2.11"},{"date":"2024-09-30","value":"0.85","vol":"2.43"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.30 | 1.37 | 1.67 | 1.11 | 0.85 |
| 行业 | 2.21 | 2.13 | 2.22 | 2.11 | 2.43 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 18/109 ， 24/109。
[{"date":"2025-09-30","value":"35.46","vol":"33.12"},{"date":"2025-06-30","value":"31.01","vol":"33.87"},{"date":"2025-03-31","value":"28.51","vol":"33.29"},{"date":"2024-12-31","value":"31.29","vol":"34.05"},{"date":"2024-09-30","value":"30.93","vol":"32.87"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
35.46 | 31.01 | 28.51 | 31.29 | 30.93 |
| 行业(%) | 33.12 | 33.87 | 33.29 | 34.05 | 32.87 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.64","vol":"0.75"},{"date":"2025-06-30","value":"0.52","vol":"0.74"},{"date":"2025-03-31","value":"0.46","vol":"0.72"},{"date":"2024-12-31","value":"0.53","vol":"0.75"},{"date":"2024-09-30","value":"0.51","vol":"3.20"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.64 | 0.52 | 0.46 | 0.53 | 0.51 |
| 行业(%) | 0.75 | 0.74 | 0.72 | 0.75 | 3.20 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信建投证券 | 2025-11-05 | 买入 | |
| 长城证券 | 2025-10-29 | 增持 | |
| 华泰证券 | 2025-10-27 | 买入 | |
| 国泰海通证券 | 2025-09-22 | 买入 | |
| 兴业证券 | 2025-09-15 | 增持 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"5.06","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"5.98","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"7.08","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"7.88","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"8.71","blueLineValue":"1.37","type":"YC"}]